Note*: This report requires 7-10 business days to complete.
Late-stage chronic kidney disease (CKD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Late-stage chronic kidney disease (CKD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Late-stage chronic kidney disease (CKD) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Late-stage chronic kidney disease (CKD) market.
• Identifying patient populations in the global “Late-stage chronic kidney disease (CKD)market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Late-stage chronic kidney disease (CKD) therapeutics in each of the markets covered.
• To understand the future market competition in the global Late-stage chronic kidney disease (CKD) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Late-stage chronic kidney disease (CKD) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Late-stage chronic kidney disease (CKD) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Late-stage chronic kidney disease (CKD) Market
• Global Epidemiology of Late-stage chronic kidney disease (CKD) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Late-stage chronic kidney disease (CKD) Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Late-stage chronic kidney disease (CKD) (2013-2023)
• Table 7: Late-stage chronic kidney disease (CKD) Global Market (USD Millions), (2013-2015)
• Table 8: Late-stage chronic kidney disease (CKD) Global Market (USD Millions), (2016-2023)
• Table 9: Late-stage chronic kidney disease (CKD) US Market (USD Millions), (2013-2015)
• Table 10: Late-stage chronic kidney disease (CKD) US Market (USD Millions), (2016-2023)
• Table 11: Late-stage chronic kidney disease (CKD) Germany Market (USD Millions), (2013-2015)
• Table 12: Late-stage chronic kidney disease (CKD) Germany Market (USD Millions), (2016-2023)
• Table 13: Late-stage chronic kidney disease (CKD) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Late-stage chronic kidney disease (CKD) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Late-stage chronic kidney disease (CKD) France Market (USD Millions), (2013-2015)
• Table 16: Late-stage chronic kidney disease (CKD) France Market (USD Millions), (2016-2023)
• Table 17: Late-stage chronic kidney disease (CKD) Italy Market (USD Millions), (2013-2015)
• Table 18: Late-stage chronic kidney disease (CKD) Italy Market (USD Millions), (2016-2023)
• Table 19: Late-stage chronic kidney disease (CKD) Spain Market (USD Millions), (2013-2015)
• Table 20: Late-stage chronic kidney disease (CKD) Spain Market (USD Millions), (2016-2023)
• Table 21: Late-stage chronic kidney disease (CKD) Japan Market (USD Millions), (2013-2015)
• Table 22: Late-stage chronic kidney disease (CKD) Japan Market (USD Millions), (2016-2023)
• Table 23: Late-stage chronic kidney disease (CKD) ROW Market (USD Millions), (2013-2015)
• Table 24: Late-stage chronic kidney disease (CKD) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Late-stage chronic kidney disease (CKD) Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Late-stage chronic kidney disease (CKD) (2013-2023)
• Figure 3: Late-stage chronic kidney disease (CKD) Global Market (USD Millions), (2013-2015)
• Figure 4: Late-stage chronic kidney disease (CKD) Global Market (USD Millions), (2016-2023)
• Figure 5: Late-stage chronic kidney disease (CKD) US Market (USD Millions), (2013-2015)
• Figure 6: Late-stage chronic kidney disease (CKD) US Market (USD Millions), (2016-2023)
• Figure 7: Late-stage chronic kidney disease (CKD) Germany Market (USD Millions), (2013-2015)
• Figure 8: Late-stage chronic kidney disease (CKD) Germany Market (USD Millions), (2016-2023)
• Figure 9: Late-stage chronic kidney disease (CKD) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Late-stage chronic kidney disease (CKD) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Late-stage chronic kidney disease (CKD) France Market (USD Millions), (2013-2015)
• Figure 12: Late-stage chronic kidney disease (CKD) France Market (USD Millions), (2016-2023)
• Figure 13: Late-stage chronic kidney disease (CKD) Italy Market (USD Millions), (2013-2015)
• Figure 14: Late-stage chronic kidney disease (CKD) Italy Market (USD Millions), (2016-2023)
• Figure 15: Late-stage chronic kidney disease (CKD) Spain Market (USD Millions), (2013-2015)
• Figure 16: Late-stage chronic kidney disease (CKD) Spain Market (USD Millions), (2016-2023)
• Figure 17: Late-stage chronic kidney disease (CKD) Japan Market (USD Millions), (2013-2015)
• Figure 18: Late-stage chronic kidney disease (CKD) Japan Market (USD Millions), (2015-2023)
• Figure 19: Late-stage chronic kidney disease (CKD) ROW Market (USD Millions), (2013-2015)
• Figure 20: Late-stage chronic kidney disease (CKD) ROW Market (USD Millions), (2016-2023)
• Market (7MM)
• Market forecasting
• Sales forecasting
• Market segments
• Pipeline products and technologies
• Competitive landscape
• SWOT analysis
